Liang Zheng

Since joining Kirkland & Ellis, Liang has represented:

• Certain affiliates of Bain Capital on the proposed US$3.16 billion take-private of Chindata Group Holdings Limited (NASDAQ: CD), a leading carrier-neutral hyperscale data center solution provider in Asia-Pacific emerging markets
• MoneyHero Group on its business combination with Bridgetown Holdings Limited (NASDAQ: BTWN), a special purpose acquisition company formed as a collaboration between Pacific Century Group and Thiel Capital
• COFCO Beverages (CCBMH) Limited, a subsidiary of Chinese state-owned food processing company COFCO Corporation and China Foods Limited (HKSE: 506), on the acquisition of all of the equity interests in certain wholly-owned subsidiaries of Coca-Cola Bottlers Manufacturing Holdings Limited, a joint venture ultimately owned by The Coca-Cola Company, Swire Pacific Limited (HKSE: 00019 and HKSE: 00087) and COFCO Beverages (CCBMH) Limited. This transaction was named “Deals of the Year 2022” by China Business Law Journal
• Carlyle on the acquisition of HCP Global, a leading Chinese packaging firm, from Baring Private Equity Asia. This transaction was named “Deals of the Year 2022” by China Business Law Journal
• Poema Global Holdings Corp. (NASDAQ: PPGH), a special purpose acquisition company affiliated with Princeville Capital, on its business combination with Gogoro Inc., a global technology leader in battery swapping ecosystems that enable sustainable mobility solutions for cities 
• An investor consortium comprised of Ocean Link Partners and Sequoia Capital China in the proposed privatization of Zhejiang New Century Hotel Management Co., Ltd. (HKSE: 1158) by way of a voluntary general offer

Prior to joining Kirkland & Ellis, Liang represented:

• A Chinese payment solution provider in its series C financing
• A leading investment bank, as the lead investor, in the minority investment in a global clinical/contract research organization
• A Hong Kong listed electronics manufacturer in its acquisition of a minority interest in a Japanese micro-lens manufacturer
• A Taiwan manufacturing company in its joint venture with a pension fund and a leading holding group in Turkey
• A Chinese fashion conglomerate in its proposed acquisition of a controlling stake in the holding company of an iconic department store chain in Europe
• A NASDAQ listed pharmaceutical company in its sale of a manufacturing facility to a Taiwan company.
• A private investment firm in its acquisition of an international electronics manufacturer
• A NYSE listed multinational semiconductor company in its three-tranche notes offering
• A number of global and regional investment banks as the sponsors and underwriters in the Hong Kong listing and global offering of a medical device company, a fashion menswear company and a comprehensive property developer
• An international trading company in its initial public offering and Hong Kong listing
• Two Taiwan listed companies in their respective convertible notes offerings and global depositary receipts offerings